Endocrine Abstracts

Introduction: Lutetium-177 Oxodotreotide (Lutathera) is a targeted molecular radiotherapy treatment for advanced, inoperable, progressive neuro-endocrine tumours. We present our experience of Lutathera therapy with particular focus on our experience implementing treatment as a day-case procedure, and assessment of adherence to treatment quality standards surrounding the administration.Aims: To assess safety of Lutathera as a day-case treatment.<p cla...

Background: The appropriate and timely management of diabetes-related ketoacidosis (DKA) has important implications for patient outcomes. Despite the availability of national management guidelines to promote standardised care, we do not know if there are differences in DKA outcomes and complications between hospitals.Aim: To assess for differences in DKA outcomes and treatment complications between hospitals.Methods: This retrospec...

Adrenal crisis (AC) is a life-threatening episode of adrenal insufficiency (AI) resulting from impairment of glucocorticoid secretion by the adrenal cortex. Approximately 1 in 200 patients die from AC annually.1 AC is often precipitated by intercurrent illness, injury or surgery and can be prevented by increasing oral corticosteroid doses (‘stress dosing’) during illness. Parenteral hydrocortisone may be necessary if oral therapy cannot be absorbed or inef...